Authors:
Fontaine, E
Riva, C
Peeters, M
Schmit, JC
Delaporte, E
Van Laethem, K
Van Vaerenbergh, K
Snoeck, J
Van Wijngaerden, E
De Clercq, E
Van Ranst, M
Vandamme, AM
Citation: E. Fontaine et al., Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through J, J ACQ IMM D, 28(3), 2001, pp. 254-258
Authors:
Bogaerts, J
Ahmed, J
Akhter, N
Begum, N
Rahman, M
Nahar, S
Van Ranst, M
Verhaegen, J
Citation: J. Bogaerts et al., Sexually transmitted infections among married women in Dhaka, Bangladesh: unexpected high prevalence of herpes simplex type 2 infection, SEX TRANS I, 77(2), 2001, pp. 114-119
Authors:
Van Vaerenbergh, K
Debaisieux, L
De Cabooter, N
Declercq, C
Desmet, K
Fransen, K
Maes, B
Marissens, D
Miller, K
Muyldermans, G
Sprecher, S
Stuyver, L
Vaira, D
Verhofstede, C
Zissis, G
Van Ranst, M
De Clercq, E
Desmyter, J
Vandamme, AM
Citation: K. Van Vaerenbergh et al., Prevalence of genotypic resistance among antiretroviral drug-naive HTV-1-infected patients in Belgium, ANTIVIR TH, 6(1), 2001, pp. 63-70
Authors:
Snoeck, R
Bossens, M
Parent, D
Delaere, B
Degreef, H
Van Ranst, M
Noel, JC
Wulfsohn, MS
Rooney, JF
Jaffe, HS
De Clercq, E
Citation: R. Snoeck et al., Phase II double-blind, placebo-controlled study of the safety and efficacyof cidofovir topical gel for the treatment of patients with human papillomavirus infection, CLIN INF D, 33(5), 2001, pp. 597-602
Authors:
Rector, A
Vermeire, S
Thoelen, I
Keyaerts, E
Struyf, F
Vlietinck, R
Rutgeerts, P
Van Ranst, M
Citation: A. Rector et al., Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel disease, HUM GENET, 108(3), 2001, pp. 190-193
Authors:
Van Dooren, S
Salemi, M
Pourrut, X
Peeters, M
Delaporte, E
Van Ranst, M
Vandamme, AM
Citation: S. Van Dooren et al., Evidence for a second simian T-cell lymphotropic virus type 3 in Cercopithecus nictitans from Cameroon, J VIROLOGY, 75(23), 2001, pp. 11939-11941
Authors:
Thoelen, I
Magnusson, C
Tagerud, S
Polacek, C
Lindberg, M
Van Ranst, M
Citation: I. Thoelen et al., Identification of alternative splice products encoded by the human coxsackie-adenovirus receptor gene, BIOC BIOP R, 287(1), 2001, pp. 216-222
Citation: I. Witters et al., Cytomegalovirus reactivation in pregnancy and subsequent isolated bilateral hearing loss in the infant, GEN COUNSEL, 11(4), 2000, pp. 375-378
Authors:
Van Laethem, K
Schmit, JC
Pelemans, H
Balzarini, J
Witvrouw, M
Perez-Perez, MJ
Camarasa, MJ
Esnouf, RM
Aquaro, S
Cenci, A
Perno, CF
Hermans, P
Sprecher, S
Ruiz, L
Clotet, B
Van Wijngaerden, E
Van Ranst, M
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Presence of 2 ',5 '-bis-O-(tert-butyldimethylsilyl)-3 '-spiro-5 ''-(4 ''-amino-1 '',2 ''-oxathiole-2 '',2 ''-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients, AIDS RES H, 16(9), 2000, pp. 825-833
Authors:
Van Laethem, K
Witvrouw, M
Balzarini, J
Schmit, JC
Sprecher, S
Hermans, P
Leal, M
Harrer, T
Ruiz, L
Clotet, B
Van Ranst, M
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir, AIDS, 14(4), 2000, pp. 469-471
Authors:
Sasse, A
Liesnard, C
van der Groen, G
Burtonboy, G
Plum, J
Sondag-Thull, D
Sprecher, S
Van Ranst, M
Zissis, G
Desmyter, J
Citation: A. Sasse et al., Recent increase in diagnoses of HIV infections based on surveillance system data in Belgium, AIDS, 14(17), 2000, pp. 2798-2800
Authors:
Van Laethem, K
Van Vaerenbergh, K
Schmit, JC
Sprecher, S
Hermans, P
De Vroey, V
Schuurman, R
Harrer, T
Witvrouw, M
Van Wijngaerden, E
Stuyver, L
Van Ranst, M
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations, J ACQ IMM D, 22(2), 1999, pp. 107-118
Authors:
Bogaerts, J
Ahmed, J
Akhter, N
Begum, N
Van Ranst, M
Verhaegen, J
Citation: J. Bogaerts et al., Sexually transmitted infections in a basic healthcare clinic in Dhaka, Bangladesh: syndromic management for cervicitis is not justified, SEX TRANS I, 75(6), 1999, pp. 437-438
Authors:
Struyf, F
Lemmens, A
Valadas, E
Verhaegen, J
Van Ranst, M
Citation: F. Struyf et al., Usefulness of immunochromatographic detection of antibodies to Mycobacterium tuberculosis as an adjunct to auramine staining for rapid diagnosis of tuberculosis in a low-prevalence setting, EUR J CL M, 18(10), 1999, pp. 740-742
Authors:
Tachezy, R
Mikyskova, I
Salakova, M
Van Ranst, M
Citation: R. Tachezy et al., Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine/proline polymorphism, HUM GENET, 105(6), 1999, pp. 564-566
Authors:
Tachezy, R
Hamsikova, E
Hajek, T
Mikyskova, I
Smahel, M
Van Ranst, M
Kanka, J
Havrankova, A
Rob, L
Guttner, V
Slavik, V
Anton, M
Kratochvil, B
Kotrsova, L
Vonka, V
Citation: R. Tachezy et al., Human papillomavirus genotype spectrum in Czech women: Correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles, J MED VIROL, 58(4), 1999, pp. 378-386
Authors:
Vandamme, AM
Van Laethem, K
Schmit, JC
Van Wijngaerden, E
Reynders, M
Debyser, Z
Witvrouw, M
Van Ranst, M
De Clercq, E
Desmyter, J
Citation: Am. Vandamme et al., Long-term stability of human immunodeficiency virus viral load and infectivity in whole blood, EUR J CL IN, 29(5), 1999, pp. 445-452